Device Trial Radar · NCT05242276
Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Mar 20, 2022
Primary completion
Mar 20, 2024
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Instituto de Investigacion Sanitaria La FeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 16, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The uterine manipulator is a device commonly used in minimally invasive hysterectomy surgery for endometrial cancer. However, without substantial evidence to support its use, surgeons are required to make decisions about its use based only on their personal choice and surgical experience. A retrospective study demonstrated how uterine manipulator use in early-stage endometrial cancer (FIGO I-II) for minimally invasive surgery was associated with a worse oncologic outcome in patients with uterus-confined endometrial cancer (FIGO I-II) who underwent minimally invasive surgery. The main objective of this study is to prospectively confirm the results obtained retrospectively, assessing the relapse rate in these patients related to the use or not of a uterine manipulator during the endometrial surgery. Secondary, the presence of risk factors that contraindicate the use of the uterine manipulator will also be evaluated.
Conditions
- Endometrial Cancer
Interventions
USE OF UTERINE MANIPULATOR DURING THE HYSTERECTOMYDevice
The uterine manipulator is a device commonly used in minimally invasive hysterectomy surgery for endometrial cancer. However, without substantial evidence to support its use, surgeons are required to make decisions about its use based only on their personal choice and surgical experience. . It is inserted vaginally through the cervical canal into the endometrial cavity. The uterine manipulator facilitates the uterus mobilization during the surgery, generating tension on the main supporting elements of the uterus to improve surgical field exposure and provide a landmark for the colpotomy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relapse rateTime frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital universitario y politécnico La Fe
Valencia, Valencia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.